ENGAGE AF-TIMI 48 HF Subscore Calculator

Clinical calculation support · Verify results before clinical use

Clinical predictor inputs

Enter baseline clinical characteristics to calculate the model-derived relative hazard multiplier.

10 predictors

Age entered in years; model coefficient is per 10-year increment.

Select whether creatinine clearance is ≤50 mL/min.

Select whether left ventricular ejection fraction is below 50%.

Current use at baseline.

Baseline heart rate in beats per minute.

Reset calculator

About this clinical model

The ENGAGE AF–TIMI 48 analysis evaluated clinical predictors of a composite endpoint of heart-failure hospitalization, death due to heart failure, or sudden cardiac death among patients with atrial fibrillation without a previous history of heart failure.

The conference report describes 8,981 patients and 589 composite events (6.5%) over a median 2.8-year follow-up. The clinical model had a c-statistic of 0.66. NT-proBNP and troponin provided additional prognostic information when available.

Predictors included in this implementation

PredictorModel coding
AgePer 10-year increment
Creatinine clearance≤50 mL/min
LVEF<50%
Loop diuretic useYes/no
Heart ratePer bpm
Diabetes, valve disease, prior stroke/TIA, CAD, hypertensionYes/no

Interpretation and limitations

  • This tool reproduces the original code's coefficient-based calculation; it is not an officially validated ENGAGE AF–TIMI 48 risk score.
  • The reference profile is a computational comparator, not necessarily a representative or clinically meaningful patient.
  • Predictor coefficients, units, and coding should be checked against the complete primary report before clinical use.
  • Biomarkers are not included in this implementation.
  • Use clinical assessment and validated tools as appropriate; do not base treatment decisions on this output alone.
Clinical disclaimer: For educational and research support only. Not a substitute for clinical judgment, and not intended for independent diagnosis, prognosis, or treatment decisions.

References

Inciardi RM, Giugliano RP, Nordio F, et al. Heart Failure hospitalization and mortality in non-valvular Atrial Fibrillation: The ENGAGE-AF TIMI 48 Trial. European Heart Journal. 2019;40(Suppl 1):ehz745.0390. https://doi.org/10.1093/eurheartj/ehz745.0390.

The abstract supports the cohort size, endpoint, event rate, follow-up, predictor associations, c-statistic, and added value of biomarkers; it does not independently verify every coefficient currently embedded in the original PHP.